Pnc Financial Services Group, Inc. Neogenomics Inc Transaction History

Pnc Financial Services Group, Inc.

  • $162 Billion
  • Q3 2025

A detailed history of Pnc Financial Services Group, Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 18,095 shares of NEO stock, worth $187,102. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,095
Previous 15,530 16.52%
Holding current value
$187,102
Previous $113,000 23.01%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
BUY
$4.84 - $8.81 $12,414 - $22,597
2,565 Added 16.52%
18,095 $139,000
Q2 2025

Aug 08, 2025
BUY
$6.4 - $10.27 $71,520 - $114,767
11,175 Added 256.6%
15,530 $113,000
Q1 2025

May 09, 2025
SELL
$9.09 - $18.61 $102,307 - $209,455
-11,255 Reduced 72.1%
4,355 $41,000
Q4 2024

Feb 07, 2025
BUY
$13.0 - $18.43 $10,010 - $14,191
770 Added 5.19%
15,610 $257,000
Q3 2024

Nov 08, 2024
SELL
$13.4 - $17.73 $14,740 - $19,503
-1,100 Reduced 6.9%
14,840 $218,000
Q2 2024

Aug 09, 2024
SELL
$13.01 - $15.77 $59,885 - $72,589
-4,603 Reduced 22.41%
15,940 $221,000
Q1 2024

May 10, 2024
BUY
$14.06 - $16.79 $170,252 - $203,310
12,109 Added 143.57%
20,543 $322,000
Q4 2023

Feb 09, 2024
BUY
$11.67 - $20.73 $20,900 - $37,127
1,791 Added 26.96%
8,434 $136,000
Q3 2023

Nov 13, 2023
SELL
$12.15 - $17.85 $10,983 - $16,136
-904 Reduced 11.98%
6,643 $81,000
Q2 2023

Aug 11, 2023
SELL
$14.1 - $19.83 $12,577 - $17,688
-892 Reduced 10.57%
7,547 $121,000
Q1 2023

May 15, 2023
BUY
$9.09 - $19.45 $5,572 - $11,922
613 Added 7.83%
8,439 $146,000
Q4 2022

Feb 10, 2023
SELL
$6.45 - $12.07 $58,591 - $109,643
-9,084 Reduced 53.72%
7,826 $72,000
Q3 2022

Nov 10, 2022
BUY
$7.86 - $12.91 $47,608 - $78,195
6,057 Added 55.81%
16,910 $145,000
Q2 2022

Aug 12, 2022
SELL
$7.06 - $13.97 $55,802 - $110,418
-7,904 Reduced 42.14%
10,853 $88,000
Q1 2022

May 12, 2022
SELL
$12.15 - $35.28 $89,083 - $258,672
-7,332 Reduced 28.1%
18,757 $227,000
Q4 2021

Feb 11, 2022
SELL
$30.49 - $48.49 $63,693 - $101,295
-2,089 Reduced 7.41%
26,089 $890,000
Q3 2021

Nov 05, 2021
BUY
$41.66 - $52.52 $79,570 - $100,313
1,910 Added 7.27%
28,178 $1.36 Million
Q2 2021

Aug 06, 2021
BUY
$36.62 - $51.69 $4,614 - $6,512
126 Added 0.48%
26,268 $1.19 Million
Q1 2021

May 07, 2021
SELL
$41.56 - $59.88 $54,609 - $78,682
-1,314 Reduced 4.79%
26,142 $1.26 Million
Q4 2020

Feb 12, 2021
SELL
$36.08 - $56.47 $344,058 - $538,497
-9,536 Reduced 25.78%
27,456 $1.48 Million
Q3 2020

Nov 06, 2020
BUY
$33.26 - $40.48 $54,413 - $66,225
1,636 Added 4.63%
36,992 $1.36 Million
Q2 2020

Aug 07, 2020
BUY
$24.21 - $31.02 $226,024 - $289,602
9,336 Added 35.88%
35,356 $1.1 Million
Q1 2020

May 08, 2020
SELL
$20.5 - $34.53 $26,732 - $45,027
-1,304 Reduced 4.77%
26,020 $718,000
Q4 2019

Feb 07, 2020
BUY
$18.96 - $29.84 $181,712 - $285,986
9,584 Added 54.02%
27,324 $799,000
Q3 2019

Nov 08, 2019
SELL
$19.12 - $26.24 $358,939 - $492,603
-18,773 Reduced 51.41%
17,740 $339,000
Q2 2019

Aug 09, 2019
SELL
$19.57 - $24.1 $18,160 - $22,364
-928 Reduced 2.48%
36,513 $0
Q1 2019

May 10, 2019
BUY
$12.14 - $20.46 $54,496 - $91,844
4,489 Added 13.62%
37,441 $0
Q4 2018

Feb 08, 2019
SELL
$11.24 - $18.5 $224,800 - $370,000
-20,000 Reduced 37.77%
32,952 $415,000
Q3 2018

Nov 09, 2018
BUY
$12.5 - $15.38 $402,500 - $495,236
32,200 Added 155.17%
52,952 $0
Q2 2018

Aug 10, 2018
BUY
$7.99 - $14.05 $165,808 - $291,565
20,752 New
20,752 $0

Others Institutions Holding NEO

# of Institutions
291
Shares Held
131M
Call Options Held
1.3M
Put Options Held
395K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.3B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email